Bio-Gate
Company that employs unique silver technology to endow materials and products with antimicrobial properties.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
N/A | Spinout | ||
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 22 % | 2 % | (38 %) | 42 % | 40 % | 19 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 8 % | 1 % | (27 %) | (22 %) | (11 %) | (6 %) | (26 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (1 %) | (3 %) | (33 %) | (31 %) | (16 %) | (9 %) | (30 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Bio-Gate AG is a publicly held German medical technology company that specializes in leveraging silver's antimicrobial properties to enhance materials and products across various sectors. Founded in 2005 and headquartered in Nuremberg, the company has established itself by focusing on technologies that prevent infections and improve health and hygiene.
The company's business model revolves around the development and application of two core patented technologies: MicroSilver BG™ and HyProtect™. Revenue is generated by incorporating these technologies into partners' products or by directly selling their enhanced products. Bio-Gate serves a diverse client base that spans medical technology, dermo-cosmetics, veterinary care, and industrial applications. For the trailing twelve months as of June 30, 2024, the company reported revenue of $8.17 million. Its business is segmented, with the Dermacosmetics and Wound Care division showing significant growth.
Bio-Gate's flagship product, MicroSilver BG™, is an additive composed of highly pure, porous, micro-sized silver particles. Developed through a purely physical process without chemical additives, it offers long-lasting antimicrobial and antiviral effects. This technology is integrated into a wide array of products, including skincare, oral care, wound dressings, and even industrial items like paints and plastics. A key feature is its safety and biocompatibility, as the micro-sized particles do not penetrate the skin, making it suitable for daily use and for individuals with conditions like atopic dermatitis or acne. The second core technology, HyProtect™, is an ultrathin plasma coating containing pure silver that protects medical implant surfaces from bacterial colonization. This is particularly crucial for orthopedic, trauma, and dental implants, where preventing implant-associated infections is critical. Bio-Gate has successfully applied this coating to titanium revision implants, reducing reinfection risks for patients worldwide.
Keywords: antimicrobial technologies, silver coating, medical technology, infection prevention, MicroSilver BG, HyProtect, dermo-cosmetics, implant coating, veterinary hygiene, antimicrobial additives, health solutions, hygiene solutions, wound care, plasma coating, material enhancement, pathogen protection, biocompatible materials, orthopedic implants, industrial applications, animal care products, skin care actives